SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-22-005980
Filing Date
2022-04-26
Accepted
2022-04-26 16:10:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20220426xdefa14a.htm DEFA14A 16022
2 GRAPHIC tmb-20220426xdefa14a003.jpg GRAPHIC 210655
3 GRAPHIC tmb-20220426xdefa14a004.jpg GRAPHIC 141442
  Complete submission text file 0001558370-22-005980.txt   502104
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40925 | Film No.: 22854416
SIC: 2834 Pharmaceutical Preparations